RHPRG4 FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)

NCT06495307 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class

Stopped Efficacy signal substantial enough to more to larger study

Conditions

Interventions

Sponsor

Lubris Bio Pty Ltd

Collaborators